Clinical trial
Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic…
NCT00396604 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00396604 |
|---|---|
| Title | Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD) |
| Official title | A Randomized, Double-blind, Double-dummy, Active (Formoterol 12 µg b.i.d) and Placebo Controlled, Multi-center, 5 Period Crossover Study to Assess the Bronchodilatory Efficacy and Safety of Single Doses of Indacaterol 150 µg, 300 µg and 600 µg Delivered Via Single Dose Dry Powder Inhaler vs. Placebo… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive, COPD, Lung Diseases, Obstructive |
| Intervention type | Drug |
| Interventions | indacaterol maleate |
| Enrollment | 51 |
| Start date | Oct 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Nov 7, 2006 |
| Last update posted | Oct 25, 2011 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: